🔗 Permalink

Inventor profile of:

Manfred Schuster

City:

Schrick

Country:

Austria

Published Applications:

Last publication date:

2015-11-05

Top Assignees for applications by Manfred Schuster

The entities that hold a legal rights for patent applications filed by inventor Schuster Manfred:

APEIRON BIOLOGICS AG 6 Vienna, Austria
GREENOVATION BIOTECH GMBH 5 Freiburg, Germany
Meridian Biopharmaceuticals GmbH 2 Vienna, Austria
MERIDIAN BIOPHARMACEUTICALS GMBH 2 Wien, Austria
IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS- UND ENTWICKLUNGS-AG 1 Wien, Austria
Igeneon Krebs-Immuntherapie Forschungs-Und Entwicklungs-AG 1 Vienna, Australia
Apeiron Biologics Forschungs-und Entwicklungsgesellschaft m.b.H. 1 Vienna, Austria
MEDIZINISCHE UNIVERSITAT INNSBRUCK 1 Innsbruck, Austria
Apeiron Biologics AG 1 , Austria
Medizinische Universitaet Innsbruck 1 Innsbruck, Austria
IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG 1 Vienna, Austria
Apeiron Biologics Forschungs- Und Entwicklungsgese llschaft M.B.H. 1 Vienna, Austria

Recent patent applications by Schuster Manfred

Manfred Schuster from Schrick, AT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2015-11-05

US20150313931A1

Human necessities

SIRNA AGAINST CBL-B AND OPTIONALLY IL-2 AND IL-12 FOR USE IN THE TREATMENT OF CANCER

#2 | 2015-10-08

US20150284461A1

Chemistry; metallurgy

Glyco-engineered antibodies

#3 | 2014-04-10

US20140099297A1

Human necessities

ACE2 POLYPEPTIDE

#4 | 2014-01-09

US20140010781A1

Human necessities

SiRNA against Cbl-b and optionally IL-2 and IL-12 for use in the treatment of cancer

#5 | 2012-02-16

US20120040864A1

Physics

Method for Determining the Cbl-b Expression

#6 | 2011-02-10

US20110033524A1

Human necessities

Treatment of tumors

#7 | 2011-01-27

US20110020331A1

Chemistry; metallurgy

Method of treating lewis Y-expressing tumors

#8 | 2011-01-27

US20110020315A1

Human necessities

Treatment of inflammatory illnesses with ACE2

#9 | 2010-12-16

US20100316624A1

Human necessities

TREATMENT OF FIBROSES AND LIVER DISORDERS

#10 | 2010-12-09

US20100310551A1

Human necessities

IMMUNOGENIC, MONOCLONAL ANTIBODY

#11 | 2010-12-09

US20100310546A1

Human necessities

Recombinant ACE2 polypeptide dimer

#12 | 2010-10-14

US20100261214A1

Physics

Method for determining ACE2 activity

#13 | 2010-10-14

US20100260808A1

Chemistry; metallurgy

Method for increasing immunoreactivity

#14 | 2009-11-26

US20090291078A1

Chemistry; metallurgy

Glyco-engineered antibodies

#15 | 2008-04-24

US20080095783A1

Chemistry; metallurgy

N-glycosylated antibody

#16 | 2007-11-08

US20070258978A1

Chemistry; metallurgy

Immunogenic recombinant antibody

#17 | 2007-10-18

US20070243201A1

Chemistry; metallurgy

Method for Selecting Epitopes for Immunotherapy

#18 | 2006-01-26

US20060018901A1

Chemistry; metallurgy

Use of antibodies in a very low dose for the vaccination against cancer

#19 | 2005-08-18

US20050181475A1

Human necessities

Immunogenic monoclonal antibody

InventorID:

604861 ⎘